Correction to "Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin"

Jackson E. H. Brunicardi,James H. Griffin,Michael J. Ferracane,Adam G. Kreutzer,Jeramiah Small,Ana-Teresa Mendoza,Joseph W. Ziller,James S. Nowick

DOI: https://doi.org/10.1021/acs.joc.4c02243

2024-09-26

The Journal of Organic Chemistry

Abstract:J Org Chem . 2024 Sep 25. doi: 10.1021/acs.joc.4c02243. Online ahead of print. NO

chemistry, organic

What problem does this paper attempt to address?

Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin

Jackson E. H. Brunicardi,James H. Griffin,Michael J. Ferracane,Adam G. Kreutzer,Jeramiah Small,Ana-Teresa Mendoza,Joseph W. Ziller,James S. Nowick

DOI: https://doi.org/10.1021/acs.joc.4c01414

2024-08-26

The Journal of Organic Chemistry

Abstract:Our laboratory reported the chemical synthesis and stereochemical assignment of the recently discovered peptide antibiotic clovibactin. The current paper reports an improved, gram-scale synthesis of the amino acid building block Fmoc-(2R,3R)-3-hydroxyasparagine-OH that enables structure-activity relationship studies of clovibactin. An alanine scan reveals that residues Phe(1), d-Leu(2), Ser(4), Leu(7), and Leu(8) are important for antibiotic activity. The side-chain amide group of the rare...

chemistry, organic
Correction to "Design, Synthesis, and Mechanistic Studies of ( R )-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"

Allison N. Devitt,Abigail L. Vargas,Wei Zhu,Benjamin James Des Soye,Fatma Ayaloglu Butun,Tyler Alt,Nicholas Kaley,Glaucio M. Ferreira,Graham R. Moran,Neil L. Kelleher,Dali Liu,Richard B. Silverman

DOI: https://doi.org/10.1021/acschembio.4c00478

IF: 4.634

2024-07-19

ACS Chemical Biology

Abstract:ACS Chem Biol . 2024 Jul 18. doi: 10.1021/acschembio.4c00478. Online ahead of print. NO

biochemistry & molecular biology
Corrigendum to "Structure-activity correlations for peptaibols obtained from clade Longibrachiatum of Trichoderma: A combined experimental and computational approach" [Comput Struct Biotechnol J, 21, 2023, 1860-1873]

Dóra Balázs,Tamás Marik,András Szekeres,Csaba Vágvölgyi,László Kredics,Chetna Tyagi

DOI: https://doi.org/10.1016/j.csbj.2024.08.001

2024-08-12

Abstract:[This corrects the article DOI: 10.1016/j.csbj.2023.02.046.].
Synthesis and structure-activity study of the antimicrobial lipopeptide brevibacillin

Omar Fliss,Louis-David Guay,Ismail Fliss,Éric Biron

DOI: https://doi.org/10.1039/d4md00612g

2024-09-25

Abstract:The antimicrobial lipopeptide brevibacillin is a non-ribosomally synthesized peptide produced by Brevibacillus laterosporus with inhibitory activity against several clinically relevant Gram-positive pathogenic bacteria such as Staphylococcus aureus, Listeria monocytogenes, and Clostridium difficile. In this study, we report the total synthesis of brevibacillin and analogues thereof as well as structure-activity relationship and cytotoxicity studies. Several novel synthetic analogues exhibited high inhibitory activities with minimal inhibitory concentration values in the low micromolar range against several bacteria including Gram-positive L. monocytogenes, S. aureus, Enterococcus faecalis, and Clostridium perfringens as well as Gram-negative Campylobacter coli and Pseudomonas aeruginosa. Of particular interest, four analogues showed a broad spectrum of action and greater antimicrobial activity versus cytotoxicity ratios than native brevibacillin. With a more accessible and efficient production process and improved pharmacological properties, these synthetic analogues are promising candidates to prevent and control the proliferation of various pathogens in the food industry as well as veterinary and human medicine.
Correction to "A Vancomycin-Templated DNA-Encoded Library for Combating Drug-Resistant Bacteria"

Dongliang Guan,Jiaxiang Liu,Feifei Chen,Jian Li,Xiaowen Wang,Weiwei Lu,Yanrui Suo,Feng Tang,Lefu Lan,Xiaojie Lu,Wei Huang

DOI: https://doi.org/10.1021/acs.jmedchem.4c00607

IF: 8.039

2024-04-04

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Apr 2. doi: 10.1021/acs.jmedchem.4c00607. Online ahead of print. NO

chemistry, medicinal
Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin

Chenglong Chen,Yuyao Yin,Panrui Lu,Ting Han,Hui Wang,Chao Li

DOI: https://doi.org/10.1002/anie.202415439

2024-10-02

Angewandte Chemie International Edition

Abstract:Kibdelomycin (KBD) and amycolamicin (AMM) are potent natural antibiotics effective against antibiotic-resistant Gram-positive pathogens, including vancomycin-intermediate Staphylococcus aureus (S. aureus, VISA), methicillin-resistant S. aureus (MRSA), and quinolone-resistant S. aureus (QRSA). Their antibacterial activity stems from an unprecedented dual mechanism: the lower binding sites occupy the adenosine triphosphate (ATP) binding pocket of bacterial type II topoisomerases, while the upper binding sites disrupt the enzyme dimer interface. This dual action, combined with their unique chemical structures, positions KBD and AMM as promising scaffolds for developing new antibiotics. However, the structure-activity relationship (SAR) of KBD/AMM remains underexplored due to their highly complex chemical structures. In this study, we utilized total synthesis to produce KBD/AMM analogs with various site modifications and evaluated their antimicrobial activities. Our findings establish the first comprehensive SAR for KBD/AMM, paving the way for the development of novel KBD/AMM-based antibiotics.

chemistry, multidisciplinary
Correction to "Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure-Activity Relationships of the Novel PPP4pT Series''

Tharushi P Wijesinghe,Busra Kaya,Miguel A Gonzálvez,Jeffrey R Harmer,Mahan Gholam Azad,Paul V Bernhardt,Mahendiran Dharmasivam,Des R Richardson

DOI: https://doi.org/10.1021/acs.jmedchem.4c00714

IF: 8.039

2024-04-11

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Apr 10. doi: 10.1021/acs.jmedchem.4c00714. Online ahead of print. NO

chemistry, medicinal
Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”

Behnoush Hajian,Sulyman Barkho,Hyang Yeon Lee,Malik Raynor,Diana Caridha,Angela Zaino,Mark Zak,Mrinal Shekhar,Diana Hunt,Xiannu Jin,Chau Vuong,Kristina Pannone,Erica N. Parker,Brett N. Cain,Rebecca J. Ulrich,Emily J. Geddes,John D. Williams,Jason M. Rohde,Kristen A. Muñoz,Kara M. Rzasa,Emily R. Temple,Aya M. Kelly,Michael P. Mulligan,Katie K. Lee,Gee W. Lau,Deborah T. Hung,Paul J. Hergenrother

DOI: https://doi.org/10.1021/acscentsci.2c00969

IF: 18.2

2022-09-06

ACS Central Science

Abstract:[This corrects the article DOI: 10.1021/acscentsci.2c00598.].

chemistry, multidisciplinary
Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Geetika Dhanda,Yash Acharya,Jayanta Haldar

DOI: https://doi.org/10.1021/acsomega.4c05153

IF: 4.1

2024-06-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00312.][This corrects the article DOI: 10.1021/acsomega.3c03063.].
Correction: Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis

Edward Marschall,Rachel W. Cass,Komal M. Prasad,James D. Swarbrick,Alasdair I. McKay,Jennifer A. E. Payne,Max J. Cryle,Julien Tailhades

DOI: https://doi.org/10.1039/d3sc90245e

IF: 8.4

2024-01-06

Chemical Science

Abstract:Correction for 'Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis' by Edward Marschall et al. , Chem. Sci. , 2024, 15 , 195–203, https://doi.org/10.1039/D3SC01944F.

chemistry, multidisciplinary
Author Correction: Structural basis of pH-dependent activation in a CLC transporter

Eva Fortea,Sangyun Lee,Rahul Chadda,Yiorgos Argyros,Priyanka Sandal,Robyn Mahoney-Kruszka,Hatice Didar Ciftci,Maria E. Falzone,Gerard Huysmans,Janice L. Robertson,Olga Boudker,Alessio Accardi

DOI: https://doi.org/10.1038/s41594-024-01242-5

2024-02-16

Nature Structural & Molecular Biology

Abstract:Nature Structural & Molecular Biology, Published online: 14 February 2024; doi:10.1038/s41594-024-01242-5 Author Correction: Structural basis of pH-dependent activation in a CLC transporter

cell biology,biochemistry & molecular biology,biophysics
Correction to "Stable Axially Chiral Isomers of Arylnaphthalene Lignan Glycosides with Antiviral Potential Discovered from Justicia procumbens "

Yang Zhao,Chuen-Fai Ku,Xin-Ya Xu,Nga-Yi Tsang,Yu Zhu,Chen-Liang Zhao,Kang-Lun Liu,Chuang-Chuang Li,Lijun Rong,Hong-Jie Zhang

DOI: https://doi.org/10.1021/acs.joc.4c01633

2024-08-22

The Journal of Organic Chemistry

Abstract:J Org Chem . 2024 Aug 20. doi: 10.1021/acs.joc.4c01633. Online ahead of print. NO

chemistry, organic
Correction: Analysis of the Quantitative Structure–activity Relationship of Glutathione-Derived Peptides Based on Different Free Radical Scavenging Systems

Wenzhen Liao,Longjian Gu,Yamei Zheng,Zisheng Zhu,Ming Zhao,Ming Liang,Jiaoyan Ren

DOI: https://doi.org/10.1039/c6md90050j

2016-01-01

MedChemComm

Abstract:Correction for ‘Analysis of the quantitative structure–activity relationship of glutathione-derived peptides based on different free radical scavenging systems’ by Wenzhen Liao et al., Med. Chem. Commun., 2016, DOI: 10.1039/c6md00006a.
Correction to "Antibacterial Mechanism of d-Cysteine/Polyethylene Glycol-Functionalized Gold Nanoparticles and Their Potential for the Treatment of Bacterial Infections"

Yuelong Xu,He Wang,Changrui Xing,Jianhao Zhang,Wenjing Yan

DOI: https://doi.org/10.1021/acsami.4c14064

IF: 9.5

2024-09-16

ACS Applied Materials & Interfaces

Abstract:ACS Appl Mater Interfaces . 2024 Sep 13. doi: 10.1021/acsami.4c14064. Online ahead of print. NO

materials science, multidisciplinary,nanoscience & nanotechnology
Correction to "The New Frontier: Merging Molecular Glue Degrader and Antibody-Drug Conjugate Modalities To Overcome Strategic Challenges"

Yam B Poudel,Ruchita R Thakore,Eugene P Chekler

DOI: https://doi.org/10.1021/acs.jmedchem.4c02447

IF: 8.039

2024-10-19

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Oct 18. doi: 10.1021/acs.jmedchem.4c02447. Online ahead of print. NO

chemistry, medicinal
Correction to "Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements"

Zheng Chen,Maoyu Liu,Ningyu Wang,Wenjing Xiao,Jianyou Shi

DOI: https://doi.org/10.1021/acs.jmedchem.4c01106

IF: 8.039

2024-05-23

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 May 22. doi: 10.1021/acs.jmedchem.4c01106. Online ahead of print. NO

chemistry, medicinal
Correction to "Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor"

Hongyue Liu,Pengfei Yan,Hongbo Han,Zhaoyu Zhang,Qingtong Zhou,Jian Zhang,Jie Zheng,Fei Xu,Wenqing Shui

DOI: https://doi.org/10.1021/jacs.4c10208

IF: 15

2024-08-28

Journal of the American Chemical Society

Abstract:J Am Chem Soc . 2024 Aug 26. doi: 10.1021/jacs.4c10208. Online ahead of print. NO

chemistry, multidisciplinary
Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Bee Ha Gan,Josephine Gaynord,Sam M. Rowe,Tomas Deingruber,David R. Spring

DOI: https://doi.org/10.1039/d1cs90109e

IF: 46.2

2022-01-01

Chemical Society Reviews

Abstract:Correction for ‘The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions’ by Bee Ha Gan et al. , Chem. Soc. Rev. , 2021, 50 , 7820–7880, DOI: 10.1039/D0CS00729C.
Correction to "Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity"

Arif Ali Mandal,Anjali Upadhyay,Apurba Mandal,Malay Nayak,Mohammad Sabeel K,Sudip Mukherjee,Samya Banerjee

DOI: https://doi.org/10.1021/acsami.4c13541

IF: 9.5

2024-08-28

ACS Applied Materials & Interfaces

Abstract:ACS Appl Mater Interfaces . 2024 Aug 25. doi: 10.1021/acsami.4c13541. Online ahead of print. NO

materials science, multidisciplinary,nanoscience & nanotechnology
Correction to "Glutamate Mediates Proton-Coupled Electron Transfer Between Tyrosines 730 and 731 in Escherichia coli Ribonucleotide Reductase"

Clorice R Reinhardt,Elvira R Sayfutyarova,Jiayun Zhong,Sharon Hammes-Schiffer

DOI: https://doi.org/10.1021/jacs.4c12458

IF: 15

2024-10-09

Journal of the American Chemical Society

Abstract:J Am Chem Soc . 2024 Oct 8. doi: 10.1021/jacs.4c12458. Online ahead of print. NO

chemistry, multidisciplinary

Correction to "Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin"

Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin

Correction to "Design, Synthesis, and Mechanistic Studies of ( R )-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"

Corrigendum to "Structure-activity correlations for peptaibols obtained from clade Longibrachiatum of Trichoderma: A combined experimental and computational approach" [Comput Struct Biotechnol J, 21, 2023, 1860-1873]

Synthesis and structure-activity study of the antimicrobial lipopeptide brevibacillin

Correction to "A Vancomycin-Templated DNA-Encoded Library for Combating Drug-Resistant Bacteria"

Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin

Correction to "Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure-Activity Relationships of the Novel PPP4pT Series''

Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”

Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Correction: Synthetic ramoplanin analogues are accessible by effective incorporation of arylglycines in solid-phase peptide synthesis

Author Correction: Structural basis of pH-dependent activation in a CLC transporter

Correction to "Stable Axially Chiral Isomers of Arylnaphthalene Lignan Glycosides with Antiviral Potential Discovered from Justicia procumbens "

Correction: Analysis of the Quantitative Structure–activity Relationship of Glutathione-Derived Peptides Based on Different Free Radical Scavenging Systems

Correction to "Antibacterial Mechanism of d-Cysteine/Polyethylene Glycol-Functionalized Gold Nanoparticles and Their Potential for the Treatment of Bacterial Infections"

Correction to "The New Frontier: Merging Molecular Glue Degrader and Antibody-Drug Conjugate Modalities To Overcome Strategic Challenges"

Correction to "Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements"

Correction to "Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor"

Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Correction to "Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity"

Correction to "Glutamate Mediates Proton-Coupled Electron Transfer Between Tyrosines 730 and 731 in Escherichia coli Ribonucleotide Reductase"